Greenwich LifeSciences
GLSI
30 hedge funds and large institutions have $36.3M invested in Greenwich LifeSciences in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 6 closing their positions.
308% more capital invested
Capital invested by funds: $8.9M → $36.3M (+$27.4M)
183% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 6
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
58% more funds holding
Funds holding: 19 → 30 (+11)
4.26% more ownership
Funds ownership: 2.02% → 6.29% (+4.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$10.6M |
| 2 |
BlackRock
New York
|
+$5.83M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.9M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.43M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$573K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$663K |
| 2 |
HF
HRT Financial
New York
|
-$373K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$368K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$251K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$243K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $13K | -$59.2K | -1,565 | -84% |
|
27
Wells Fargo
San Francisco,
California
| $6K | -$38.2K | -1,009 | -89% |
|
28
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $4K | +$3.78K | +100 | New |
|
|
NSIM
29
North Star Investment Management
Chicago,
Illinois
| $2K | – | – | – |
|
|
AIG
30
American International Group
New York
| $102 | +$85.5K | +2,262 | New |
|
|
31
Millennium Management
New York
| – | -$663K | -19,450 | Closed |
|
|
HF
32
HRT Financial
New York
| – | -$373K | -10,952 | Closed |
|
|
33
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$368K | -10,809 | Closed |
|
|
34
Creative Planning
Overland Park,
Kansas
| – | -$251K | -7,351 | Closed |
|
|
35
Citadel Advisors
Miami,
Florida
| – | -$243K | -7,114 | Closed |
|
|
FDCDDQ
36
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$6.82K | -200 | Closed |
|
GLSI Hedge Fund Activity: Q2 2021 in Review
30 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q2 2021, worth a combined $36.3M — up 308% from $8.9M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new GLSI positions and 6 closed out — a net gain of 11 holders — while 8 added to existing stakes and 3 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $10.6M. The largest seller was Millennium Management, exiting entirely with an estimated $663K sold.
- 30 institutional investors held Greenwich LifeSciences (GLSI) as of Q2 2021, up from 19 in Q1 2021.
- Funds reported $36.3M of Greenwich LifeSciences stock for Q2 2021, up 308% quarter-over-quarter.
- 17 funds opened new Greenwich LifeSciences positions in Q2 2021 and 6 closed out, a net change of +11 holders.
- The largest Greenwich LifeSciences buyer in Q2 2021 was Invesco, an estimated $10.6M added.
- The largest Greenwich LifeSciences seller in Q2 2021 was Millennium Management, an estimated $663K sold.
Based on aggregated 13F filings for Q2 2021.